135 related articles for article (PubMed ID: 31782138)
1. Impact of mixed cryoglobulinemia on patients with spontaneous hepatitis C virus clearance: A 13-year prospective cohort study.
Lee KC; Cheng YT; Lin CY; Kuo CJ; Chien RN; Yeh CT; Chang ML
Eur J Clin Invest; 2020 Jan; 50(1):e13189. PubMed ID: 31782138
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinaemia: an 8-year prospective study.
Cheng YT; Cheng JS; Lin CH; Chen TH; Lee KC; Chang ML
Clin Microbiol Infect; 2020 Mar; 26(3):366-372. PubMed ID: 31229596
[TBL] [Abstract][Full Text] [Related]
3. Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.
Dustin LB; Charles ED
Antivir Ther; 2012; 17(7 Pt B):1449-52. PubMed ID: 23322600
[TBL] [Abstract][Full Text] [Related]
4. Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates.
Hartmann H; Schott P; Polzien F; Mihm S; Uy A; Kaboth U; Pardowitz I; Ramadori G
Z Gastroenterol; 1995 Nov; 33(11):643-50. PubMed ID: 8600660
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.
Bonnet F; Pineau JJ; Taupin JL; Feyler A; Bonarek M; de Witte S; Bernard N; Lacoste D; Morlat P; Beylot J
J Rheumatol; 2003 Sep; 30(9):2005-10. PubMed ID: 12966606
[TBL] [Abstract][Full Text] [Related]
6. Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients.
Basile U; Gulli F; Gragnani L; Pocino K; Napodano C; Miele L; Santini SA; Marino M; Zignego AL; Rapaccini GL
Dig Liver Dis; 2018 Sep; 50(9):938-943. PubMed ID: 29709461
[TBL] [Abstract][Full Text] [Related]
7. Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia.
Cacoub P; Ghillani P; Revelen R; Thibault V; Calvez V; Charlotte F; Musset L; Youinou P; Piette JC
J Hepatol; 1999 Oct; 31(4):598-603. PubMed ID: 10551381
[TBL] [Abstract][Full Text] [Related]
8. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients.
Ferri C; Sebastiani M; Giuggioli D; Cazzato M; Longombardo G; Antonelli A; Puccini R; Michelassi C; Zignego AL
Semin Arthritis Rheum; 2004 Jun; 33(6):355-74. PubMed ID: 15190522
[TBL] [Abstract][Full Text] [Related]
9. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.
Agnello V
Springer Semin Immunopathol; 1997; 19(1):111-29. PubMed ID: 9266635
[TBL] [Abstract][Full Text] [Related]
10. Mixed cryoglobulinemia and hepatitis C virus.
Cacoub P; Fabiani FL; Musset L; Perrin M; Frangeul L; Leger JM; Huraux JM; Piette JC; Godeau P
Am J Med; 1994 Feb; 96(2):124-32. PubMed ID: 7509124
[TBL] [Abstract][Full Text] [Related]
11. Cryoglobulinemia.
Morra E
Hematology Am Soc Hematol Educ Program; 2005; ():368-72. PubMed ID: 16304405
[TBL] [Abstract][Full Text] [Related]
12. The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection.
Sasso EH
Ann Med Interne (Paris); 2000 Feb; 151(1):30-40. PubMed ID: 10761560
[TBL] [Abstract][Full Text] [Related]
13. Cryoglobulins Today: Detection and Immunologic Characteristics of 1,675 Positive Samples From 13,439 Patients Obtained Over Six Years.
Kolopp-Sarda MN; Nombel A; Miossec P
Arthritis Rheumatol; 2019 Nov; 71(11):1904-1912. PubMed ID: 31136095
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia.
Polzien F; Schott P; Mihm S; Ramadori G; Hartmann H
J Hepatol; 1997 Jul; 27(1):63-71. PubMed ID: 9252075
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests.
Casato M; Saadoun D; Marchetti A; Limal N; Picq C; Pantano P; Galanaud D; Cianci R; Duhaut P; Piette JC; Fiorilli M; Cacoub P
J Rheumatol; 2005 Mar; 32(3):484-8. PubMed ID: 15742440
[TBL] [Abstract][Full Text] [Related]
16. Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia.
Fayyazi A; Schott P; Hartmann H; Mihm S; Middel P; Ramadori G; Radzun HJ
Z Gastroenterol; 1997 Oct; 35(10):921-8. PubMed ID: 9370142
[TBL] [Abstract][Full Text] [Related]
17. Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia.
Charles ED; Orloff MI; Nishiuchi E; Marukian S; Rice CM; Dustin LB
Arthritis Rheum; 2013 Sep; 65(9):2430-40. PubMed ID: 23754128
[TBL] [Abstract][Full Text] [Related]
18. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infection.
Lamprecht P; Gutzeit O; Csernok E; Gause A; Longombardo G; Zignego AL; Gross WL; Ferri C
Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S89-94. PubMed ID: 14740433
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia.
Cacoub P; Boukli N; Hausfater P; Garbarg-Chenon A; Ghillani P; Thibault V; Musset L; Huraux JM; Piette JC
Ann Rheum Dis; 1998 Jul; 57(7):422-4. PubMed ID: 9797569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
